3 | SEC Filings Hub

Filing metadata

Accession number: 0000950170-24-107826
Form type: Form 3
Filer: Akari Therapeutics Plc
CIK: CIK 1541157
Filed: Sep 18, 2024
Reporting period: Sep 17, 2024
Description: Initial ownership

Documents

0000950170-24-107826-index.htm

Complete submission

0000950170-24-107826.txt

directory listing

Filed by

Akari Therapeutics Plc